The DOI matches its Crossref record; 16 of the 18 references it cites were found in a registry or an index.
A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
Open accessPublished version of a preprint
Abstract
The ongoing pandemic spread of a new human coronavirus, SARS-CoV-2, which is associated with severe pneumonia/disease (COVID-19), has resulted in the generation of tens of thousands of virus genome sequences. The rate of genome generation is unprecedented, yet there is currently no coherent nor accepted scheme for naming the expanding phylogenetic diversity of SARS-CoV-2. Here, we present a rational and dynamic virus nomenclature that uses a phylogenetic framework to identify those lineages that contribute most to active spread. Our system is made tractable by constraining the number and depth of hierarchical lineage labels and by flagging and delabelling virus lineages that become unobserved and hence are probably inactive. By focusing on active virus lineages and those spreading to new locations, this nomenclature will assist in tracking and understanding the patterns and determinants of the global spread of SARS-CoV-2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The B.1.617 lineage, which is divided into three sublineages according to the PANGO classification 12 , derives from the B.1 lineage (D614G).”
From Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization (2021) · cites this paper as [12]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform
Katoh, K. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf436 · Cited by 17,027
IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era
Minh, B. Q., Schmidt, H. A., Chernomor, O., Schrempf, D., Woodhams, M. D., von Haeseler, A., & Lanfear, R. (2020) · Molecular Biology and Evolution · doi:10.1093/molbev/msaa015 · Cited by 16,873
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
Self-citationA new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688
Self-citationUltrafast Approximation for Phylogenetic Bootstrap
Minh, B. Q., Nguyen, M. A. T., & von Haeseler, A. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst024 · Cited by 4,844
GISAID: Global initiative on sharing all influenza data – from vision to reality
Shu, Y., & McCauley, J. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.13.30494 · Cited by 3,039
Yang, Z. (1994) · Journal of Molecular Evolution · doi:10.1007/bf00160154 · Cited by 2,960
(1986) · Cited by 2,570
Smith, D. B., Bukh, J., KUIKEN, C. L., Muerhoff, A. S., Rice, C. M., Stapleton, J. T., & Peter Simmonds, K. (2013) · Hepatology · doi:10.1002/hep.26744 · Cited by 1,352
Cited by
Sorted by citations
Items 601–700 of 1,013
Wang, Y., Yan, A., Song, D., Duan, M., Dong, C., Chen, J., Jiang, Z., Gao, Y., Rao, M., Feng, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45050-3 · Cited by 29
Altered Subgenomic RNA Expression in SARS-CoV-2 B.1.1.7 InfectionsPreprint
Parker, M. D., Lindsey, B., Shah, D. R., Hsu, S., Keeley, A., Partridge, D., Leary, S., Cope, A., State, A., Johnson, K., et al. (2021) · bioRxiv · doi:10.1101/2021.03.02.433156 · Cited by 33
Li, Z., Nie, K., Li, K., Hu, Y., Song, Y., Kang, M., Zhang, M., Deng, X., Yuan, J., Xu, W., et al. (2021) · China CDC Weekly · doi:10.46234/ccdcw2021.151 · Cited by 29
Basile, K., Rockett, R. J., McPhie, K. A., Fennell, M., Johnson-Mackinnon, J. C., Agius, J. E., Fong, W., Rahman, H., Ko, D., Donavan, L., et al. (2022) · Viruses · doi:10.3390/v14092023 · Cited by 40
The Mutational Landscape of SARS-CoV-2
Saldivar‐Espinoza, B., Garcia‐Segura, P., Novau-Ferré, N., Macip, G., Martínez, R., Puigbò, P., Cereto‐Massagué, A., Pujadas, G., & Garcı́a-Vallvé, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24109072 · Cited by 30
Dabernig‐Heinz, J., Lohde, M., Hölzer, M., Rosel, A. C., Conzemius, R., Brandt, C., Kohl, M., Halbedel, S., Hyden, P., Fischer, M. A., et al. (2024) · Journal of Clinical Microbiology · doi:10.1128/jcm.00628-24 · Cited by 29
Phylogenetic analysis of SARS‐CoV‐2 in the first few months since its emergence
Pereson, M. J., Mojsiejczuk, L. N., Martínez, A. P., Flichman, D., Garcia, G. H., & Lello, F. A. D. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26545 · Cited by 29
Geographical Distribution of Genetic Variants and Lineages of SARS-CoV-2 in Chile
Castillo, A., Parra, B., Tapia, P., Lagos, J., Arata, L., Acevedo, A., Andrade, W., Leal, G., Tambley, C., Bustos, P., et al. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.562615 · Cited by 30
A deletion in SARS‐CoV‐2 ORF7 identified in COVID‐19 outbreak in Uruguay
Panzera, Y., Ramos, N., Frabasile, S., Calleros, L., Marandino, A. E., Tomás, G., Techera, C., Grecco, S., Fuques, E., Goñi, N., et al. (2021) · Transboundary and Emerging Diseases · doi:10.1111/tbed.14002 · Cited by 29
Pan-India novel coronavirus SARS-CoV-2 genomics and global diversity analysis in spike protein
Alai, S., Gujar, N., Joshi, M., Gautam, M., & Gairola, S. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06564 · Cited by 29
Gand, M., Vanneste, K., Thomas, I., Gucht, S. V., Capron, A., Herman, P., Roosens, N. H. C., & Keersmaecker, S. C. J. D. (2021) · Genes · doi:10.3390/genes12040565 · Cited by 29
Molina-Mora, J. A., Cordero-Laurent, E., Godínez, A., Calderón-Osorno, M., Brenes, H., Soto-Garita, C., Pérez-Corrales, C., Rica, C.-C. C. I. D. E. G. D. S.-C.-2. C., Drexler, J. F., Moreira‐Soto, A., et al. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104872 · Cited by 29
Technical framework for wastewater-based epidemiology of SARS-CoV-2
Wu, J., Wang, Z., Lin, Y., Zhang, L., Chen, J., Li, P., Liu, W., Wang, Y., Yao, C., & Yang, K. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.148271 · Cited by 29
Rapid screening method for the detection of SARS-CoV-2 variants of concern
Ong, D. S. Y., Koeleman, J. G. M., Vaessen, N., Breijer, S., Paltansing, S., & de Man, P. (2021) · Journal of Clinical Virology · doi:10.1016/j.jcv.2021.104903 · Cited by 28
High throughput diagnostics and dynamic risk assessment of SARS-CoV-2 variants of concern
Gravagnuolo, A. M., Faqih, L., Cronshaw, C., Wynn, J., Burglin, L., Klapper, P. E., & Wigglesworth, M. J. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103540 · Cited by 31
SCoV2-MD: a database for the dynamics of the SARS-CoV-2 proteome and variant impact predictions
Torrens‐Fontanals, M., Peralta-García, A., Talarico, C., Guixà-González, R., Toni Giorgino, A., & Selent, J. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab977 · Cited by 30
Genomic evidence for divergent co-infections of co-circulating SARS-CoV-2 lineages
Zhou, H., Cheng, Y., Xu, L. S., Li, J.-Y., Tao, C., Ji, C., Han, N., Yang, R., Wu, H. M., Li, Y., et al. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.07.042 · Cited by 29
Petros, B. A., Paull, J. S., Tomkins-Tinch, C. H., Loftness, B. C., DeRuff, K. C., Nair, P., Gionet, G. L., Benz, A., Brock-Fisher, T. M., Hughes, M., et al. (2022) · Med · doi:10.1016/j.medj.2022.09.003 · Cited by 28
CD8+ T-cell immune escape by SARS-CoV-2 variants of concern
Kombe, A. J. K., Biteghe, F. A. N., Ndoutoume, Z. N., & Jin, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.962079 · Cited by 29
Niesen, M. J. M., Anand, P., Silvert, E., Suratekar, R., Pawlowski, C., Ghosh, P., Lenehan, P. J., Hughes, T. K., Zemmour, D., O’Horo, J. C., et al. (2021) · medRxiv · doi:10.1101/2021.07.01.21259833 · Cited by 29
First cases of infection with the 21L/BA.2 Omicron variant in Marseille, France
Colson, P., Delerce, J., Beye, M., Levasseur, A., Boschi, C., Houhamdi, L., Tissot‐Dupont, H., Yahi, N., Million, M., Scola, B. L., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27695 · Cited by 28
A Biochemical Perspective of the Nonstructural Proteins (NSPs) and the Spike Protein of SARS CoV-2
Yoshimoto, F. K. (2021) · The Protein Journal · doi:10.1007/s10930-021-09967-8 · Cited by 28
Genomic epidemiology of COVID-19 in care homes in the east of England
Hamilton, W. L., Tonkin‐Hill, G. Q., Smith, D., Aggarwal, D., Houldcroft, C. J., Warne, B., Brown, C. S., Meredith, L. W., Hosmillo, M., Jahun, A. S., et al. (2021) · eLife · doi:10.7554/elife.64618 · Cited by 29
Identifying Primate ACE2 Variants That Confer Resistance to SARS-CoV-2
Bhattacharjee, M. J., Lin, J.-J., Chang, C.-Y., Chiou, Y.-T., Li, T., Tai, C.-W., Shiu, T.-F., Chen, C., Chou, C.-Y., Chakraborty, P., et al. (2021) · Molecular Biology and Evolution · doi:10.1093/molbev/msab060 · Cited by 28
Kaku, Y., Kuwata, T., Zahid, H. M., Hashiguchi, T., Noda, T., Kuramoto, N., Biswas, S., Matsumoto, K., Shimizu, M., Kawanami, Y., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109385 · Cited by 26
Williams, G. H., Llewelyn, A., Brandão, R. A. R., Chowdhary, K., Hardisty, K.-M., & Loddo, M. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101021 · Cited by 26
Assessment of two‐pool multiplex long‐amplicon nanopore sequencing of SARS‐CoV‐2
Liu, H., Li, J., Lin, Y., Bo, X., Song, H., Li, K., Li, P., & Ni, M. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27336 · Cited by 28
Data-driven analysis of amino acid change dynamics timely reveals SARS-CoV-2 variant emergence
Bernasconi, A., Mari, L., Casagrandi, R., & Ceri, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-00496-z · Cited by 26
Basheer, A., & Zahoor, I. (2021) · Microorganisms · doi:10.3390/microorganisms9122609 · Cited by 28
Emergence and spread of two SARS-CoV-2 variants of interest in Nigeria
Olawoye, I. B., Oluniyi, P. E., Oguzie, J. U., Uwanibe, J. N., Kayode, A. T., Olumade, T. J., Ajogbasile, F. V., Parker, E., Eromon, P., Abechi, P., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36449-5 · Cited by 27
Towards a post-pandemic future for global pathogen genome sequencing
Ladner, J. T., & Sahl, J. W. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002225 · Cited by 27
Forecast of the COVID-19 trend in India: A simple modelling approach
Song, H., Fan, G., Zhao, S., Li, H., Huang, Q., & He, D. (2021) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2021479 · Cited by 27
Estofolete, C. F., Banho, C. Á., Campos, G. R. F., Marques, B. D. C., Sacchetto, L., Ullmann, L. S., Possebon, F. S., Machado, L. F., Syrio, J. D., Araújo, J. P., et al. (2021) · Viruses · doi:10.3390/v13071237 · Cited by 27
Santos, J. D., Sobral, D., Pinheiro, M. M., Isidro, J., Bogaardt, C., Pinto, M., Eusébio, R., Santos, A., Mamede, R., Horton, D. L., et al. (2024) · Genome Medicine · doi:10.1186/s13073-024-01334-3 · Cited by 28
An Early Pandemic Analysis of SARS-CoV-2 Population Structure and Dynamics in Arizona
Ladner, J. T., Larsen, B. B., Bowers, J. R., Hepp, C. M., Bolyen, E. K., Folkerts, M., Sheridan, K. L., Pfeiffer, A., Yaglom, H. D., Lemmer, D., et al. (2020) · mBio · doi:10.1128/mbio.02107-20 · Cited by 27
Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal
Borges, V., Isidro, J., Martins, H. C., Duarte, S., Mota‐Vieira, L., Leite, R. B., Gordo, I., Caetano, C., Nunes, B., Sá, R., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1844552 · Cited by 28
Weber, S., Ramirez, C. M., Weiser, B., Burger, H., & Doerfler, W. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202114062 · Cited by 26
Bernasconi, A., Gulino, A., Alfonsi, T., Canakoglu, A., Pinoli, P., Sandionigi, A., & Ceri, S. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab478 · Cited by 27
Boshier, F. A. T., Pang, J., Penner, J., Hughes, J., Parker, M. D., Shepherd, J., Alders, N., Bamford, A., Grandjean, L., Grünewald, S., et al. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27285 · Cited by 27
Decomposing the sources of SARS-CoV-2 fitness variation in the United States
Kepler, L. M., Hamins-Puértolas, M., & Rasmussen, D. A. (2021) · Virus Evolution · doi:10.1093/ve/veab073 · Cited by 24
Inferring variant-specific effective reproduction numbers from combined case and sequencing data
Figgins, M. D., & Bedford, T. (2026) · eLife · doi:10.7554/elife.104802.2 · Cited by 25
Alteri, C., Scutari, R., Costabile, V., Colagrossi, L., Rosa, K. Y. L., Agolini, E., Lanari, V., Chiurchiù, S., Romani, L., Markowich, A. H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-14426-0 · Cited by 28
Wastewater Surveillance for SARS-CoV-2 RNA in Canada
Hrudey, S. E., Bischel, H. N., Charrois, J., Chik, A. H. S., Conant, B., Delatolla, R., Dorner, S. M., Graber, T. E., Hubert, C. R. J., Isaac-Renton, J., et al. (2022) · FACETS · doi:10.1139/facets-2022-0148 · Cited by 27
Ikewaki, N., Kurosawa, G., Levy, G. A., Preethy, S., & Abraham, S. J. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.03.005 · Cited by 27
Sapoval, N., Liu, Y., Lou, E. G., Hopkins, L., Ensor, K. B., Schneider, R., Stadler, L. B., & Treangen, T. J. (2023) · Nature Communications · doi:10.1038/s41467-023-38184-3 · Cited by 27
Dorta‐Gorrín, A., Navas, J., Gozalo-Margüello, M., Miralles, L., & García‐Hevia, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210233 · Cited by 30
SARS-CoV-2 and the host-immune response
Maison, D. P., Deng, Y., & Gerschenson, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1195871 · Cited by 29
Viral kinetics of sequential SARS-CoV-2 infections
Kissler, S. M., Hay, J. A., Fauver, J. R., Mack, C. D., Tai, C. G.-L., Anderson, D. J., Ho, D. D., Grubaugh, N. D., & Grad, Y. H. (2023) · Nature Communications · doi:10.1038/s41467-023-41941-z · Cited by 28
Tan, L. V., Hong, N. T. T., Ngoc, N. M., Thanh, T. T., Lam, V. T., Nguyet, L. A., Nhu, L. N. T., Ny, N. T. H., Minh, N. N. Q., Man, D. N. H., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.06.033 · Cited by 26
Brehm, T. T., Pfefferle, S., von Possel, R., Kobbe, R., Nörz, D. S., Schmiedel, S., Grundhoff, A. T., Olearo, F., Emmerich, P., Robitaille, A., et al. (2021) · Viruses · doi:10.3390/v13040661 · Cited by 26
The first three waves of the Covid-19 pandemic hint at a limited genetic repertoire for SARS-CoV-2
Wassenaar, T. M., Wanchai, V., Buzard, G. S., & Ussery, D. W. (2022) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuac003 · Cited by 29
Introduction and transmission of SARS-CoV-2 lineage B.1.1.7, Alpha variant, in Denmark
Michaelsen, T. Y., Bennedbæk, M., Christiansen, L. E., Jørgensen, M. S. F., Møller, C. H., Sørensen, E. A., Knutsson, S., Brandt, J., Jensen, T. B. N., Chiche-Lapierre, C., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01045-7 · Cited by 34
SARS-CoV-2 transmission routes from genetic data: A Danish case study
Blühm, A., Christandl, M., Gesmundo, F., Klausen, F. R., Mančinska, L., Steffan, V., França, D. S., & Werner, A. H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241405 · Cited by 26
SARS-CoV-2 Genomic Variation in Space and Time in Hospitalized Patients in Philadelphia
Everett, J. K., Hokama, P., Roche, A. M., Reddy, S. G., Hwang, Y., Kessler, L. R., Glascock, A. L., Li, Y., Whelan, J. N., Weiss, S. R., et al. (2021) · mBio · doi:10.1128/mbio.03456-20 · Cited by 25
Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines
Abdel-Moneim, A. S., Abdelwhab, E. M., & Memish, Z. A. (2021) · Virology · doi:10.1016/j.virol.2021.02.007 · Cited by 27
Genomic surveillance of SARS-CoV-2 in the Republic of Congo
Ntoumi, F., Mapanguy, C. C. M., Tomazatos, A., Pallerla, S. R., Linh, L. T. K., Casadei, N., Angelov, A., Sonnabend, M., Peter, S., Kremsner, P. G., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.03.036 · Cited by 26
Nicolete, V. C., Rodrigues, P. T., Johansen, I. C., Corder, R. M., Tonini, J., Cardoso, M. A., de Jesus, J. G., Claro, I. M., Faria, N. R., Sabino, É. C., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab410 · Cited by 26
Webb, L. M., Matzinger, S. R., Grano, C., Kawasaki, B., Stringer, G., Bankers, L., & Herlihy, R. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7019e2 · Cited by 26
Lind, A., Barlinn, R., Landaas, E. T., Andresen, L. L., Jakobsen, K., Fladeby, C., Nilsen, M., Bjørnstad, P. M., Sundaram, A. Y. M., Ribarska, T., et al. (2021) · Journal of Clinical Virology · doi:10.1016/j.jcv.2021.104906 · Cited by 26
Mashe, T., Takawira, F. T., Martins, L. D. O., Gudza-Mugabe, M., Chirenda, J., Munyanyi, M., Chaibva, B. V., Tarupiwa, A., Gumbo, H., Juru, A., et al. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(21)00434-4 · Cited by 25
Volkmann, A., Koopman, G., Mooij, P., Verschoor, E. J., Verstrepen, B. E., Bogers, W. M. J. M., Idorn, M., Paludan, S. R., Vang, S., Nielsen, M. A., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.857440 · Cited by 27
Agoti, C. N., Ochola‐Oyier, L. I., Dellicour, S., Mohammed, K. S., Lambisia, A. W., de Laurent, Z. R., Morobe, J. M., Mburu, M. W., Omuoyo, D. O., Ong’era, E. M., et al. (2022) · eLife · doi:10.7554/elife.71703 · Cited by 23
Interactions between heparin and SARS-CoV-2 spike glycoprotein RBD from omicron and other variants
Gelbach, A. L., Zhang, F., Kwon, S., Bates, J. T., Farmer, A. P., Dordick, J. S., Wang, C., & Linhardt, R. J. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.912887 · Cited by 26
The mechanisms of immune response and evasion by the main SARS-CoV-2 variants
Chen, Q., Zhang, J., Wang, P., & Zhang, Z. (2022) · iScience · doi:10.1016/j.isci.2022.105044 · Cited by 27
Niemeyer, D., Stenzel, S., Veith, T., Schroeder, S., Friedmann, K., Weege, F., Trimpert, J., Heinze, J., Richter, A. M., Jansen, J., et al. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001871 · Cited by 25
Long COVID Definition, Symptoms, Risk Factors, Epidemiology and Autoimmunity: A Narrative Review
Kozłowski, P., Leszczyńska, A., & Ciepiela, O. (2024) · American Journal of Medicine Open · doi:10.1016/j.ajmo.2024.100068 · Cited by 27
Genomics reveals zoonotic and sustained human mpox spread in West Africa
Parker, E., Omah, I. F., Djuicy, D. D., Magee, A. F., Tomkins-Tinch, C. H., Otieno, J. R., Varilly, P., Ayinla, A. O., Sijuwola, A. E., Ahmed, M. I., et al. (2025) · Nature · doi:10.1038/s41586-025-09128-2 · Cited by 25
Self-citationSARS-CoV-2 spread across the Colombian-Venezuelan border
Paniz‐Mondolfi, A., Muñoz, M., Flórez, C., Gomez, S., Rico, A., Pardo, L., Barros, E. C., Hernández, C., Delgado, L., Jaimes, J. E., et al. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104616 · Cited by 25
Pattabiraman, C., Habib, F., Harsha, P. K., Rasheed, R., Prasad, P., Reddy, V., Dinesh, P., Damodar, T., Hosallimath, K., George, A. K., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243412 · Cited by 26
Vrancken, B., Dellicour, S., Smith, D. M., & Chaillon, A. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab265 · Cited by 24
RetractedFeghali, R., Merhi, G., Kwasiborski, A., Hourdel, V., Ghosn, N., & Tokajian, S. T. (2021) · PeerJ · doi:10.7717/peerj.11015 · Cited by 27
Osmanodja, B., Budde, K., Zickler, D., Naik, M. G., Hofmann, J., Gertler, M., Hülso, C., Rössig, H., Horn, P., Seybold, J., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10102099 · Cited by 25
Phylogenomics reveals multiple introductions and early spread of SARS‐CoV‐2 into Peru
Juscamayta‐López, E., Carhuaricra, D., Tarazona, D. D., Valdivia, F., Rojas, N., Lenin Maturrano, H., & Gavilán, R. G. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27167 · Cited by 25
Franceschi, V. B., Ferrareze, P. A. G., Zimerman, R. A., Cybis, G. B., & Thompson, C. E. (2021) · Virus Research · doi:10.1016/j.virusres.2021.198532 · Cited by 25
Smith, M. R., Trofimova, M., Weber, A., Duport, Y., Kühnert, D., & von Kleist, M. (2021) · Nature Communications · doi:10.1038/s41467-021-26267-y · Cited by 24
Murugan, C., Ramamoorthy, S., Kuppuswamy, G. P., Murugan, R. K., Sivalingam, Y., & Sundaramurthy, A. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.10.144 · Cited by 28
Tudoran, C., Tudoran, M., Lăzureanu, V. E., Marinescu, A. R., Cut, T. G., Oancea, C. I., Pescariu, S. A., & Pop, G. N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10225272 · Cited by 25
Rapid Identification of SARS-CoV-2 Variants of Concern Using a Portable peak PCR Platform
Bechtold, P., Wagner, P., Hosch, S., Siegrist, D., Ruiz‐Serrano, A., Gregorini, M., Mpina, M., Ndoho, F. A. O., Obama, J., Ayekaba, M. O., et al. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c02368 · Cited by 26
Cunha, M. D. P., Vilela, A. P. P., Molina, C. V., Acuña, S. M., Muxel, S. M., Barroso, V. D. M., Baroni, S., de Oliveira, L. G., Angelo, Y. D. S., Peron, J. P. S., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.760170 · Cited by 24
Andrés, C., Piñana, M., Borràs-Bermejo, B., Gónzalez‐Sánchez, A., García‐Cehic, D., Esperalba, J., Rando‐Segura, A., Zules-Oña, R., de Campos, C. F., Codina, M. G., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.2011617 · Cited by 26
Barona‐Gómez, F., Delaye, L., Díaz-Valenzuela, E., Plisson, F., Cruz‐Pérez, A., Díaz-Sánchez, M., García-Sepúlveda, C. A., Sánchez‐Flores, A., Abreu, R. P., Valencia-Valdespino, F. J., et al. (2021) · Microbial Genomics · doi:10.1099/mgen.0.000684 · Cited by 24
Radu, E. L., Masseron, A., Amman, F., Schedl, A., Agerer, B., Endler, L., Penz, T., Bock, C., Bergthaler, A., Vierheilig, J., et al. (2022) · Water Research · doi:10.1016/j.watres.2022.118257 · Cited by 29
Eales, O. D., Page, A. J., Martins, L. D. O., Wang, H., Bodinier, B., Haw, D., Jonnerby, J., Atchison, C. J., Robson, S. C., Connor, T. R., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07628-4 · Cited by 23
Self-citationAntibody-mediated immunity to SARS-CoV-2 spike
Errico, J. M., Adams, L. J., & Fremont, D. H. (2022) · Advances in immunology · doi:10.1016/bs.ai.2022.07.001 · Cited by 22
Amendola, A., Canuti, M., Bianchi, S., Kumar, S., Fappani, C., Gori, M., Colzani, D., Pond, S. L. K., Miura, S., Baggieri, M., et al. (2021) · Environmental Research · doi:10.1016/j.envres.2022.113979 · Cited by 29
Harrigan, S. P., Wilton, J., Chong, M., Abdia, Y., García, H. A. V., Rose, C., Taylor, M., Mishra, S., Sander, B., Hoang, L., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac705 · Cited by 27
New RT-PCR Assay for the Detection of Current and Future SARS-CoV-2 Variants
Marchini, A., Petrillo, M., Parrish, A., Buttinger, G., Tavazzi, S., Querci, M., Betsou, F., Elsinga, G., Medema, G. J., Abdelrahman, T., et al. (2023) · Viruses · doi:10.3390/v15010206 · Cited by 23
Discovery of All- d -Peptide Inhibitors of SARS-CoV-2 3C-like Protease
Eberle, R. J., Sevenich, M. M., Gering, I., Scharbert, L., Strodel, B., Lakomek, N., Santur, K., Mohrlüder, J., Coronado, M. A., & Willbold, D. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.2c00735 · Cited by 25
Genomic epidemiology of SARS-CoV-2 variants during the first two years of the pandemic in Colombia
Jiménez-Silva, C. L., Rivero, R., Douglas, J., Bouckaert, R., Villabona‐Arenas, C. J., Atkins, K. E., Gastelbondo, B., Calderón, A., Guzmán, C., la Hoz, D. E.-D., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00328-3 · Cited by 28
Fang, L., Xu, J., Zhao, Y., Fan, J., Shen, J., Liu, W., & Cao, G. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1228128 · Cited by 26
Basile, K., Rockett, R. J., McPhie, K. A., Fennell, M., Johnson-Mackinnon, J. C., Agius, J. E., Fong, W., Rahman, H., Ko, D., Donavan, L., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.12.472252 · Cited by 25
Hirotsu, Y., Maejima, M., Shibusawa, M., Natori, Y., Nagakubo, Y., Hosaka, K., Sueki, H., Mochizuki, H., Tsutsui, T., Kakizaki, Y., et al. (2022) · Journal of Infection · doi:10.1016/j.jinf.2022.04.040 · Cited by 25
Multiple Early Introductions of SARS-CoV-2 to Cape Town, South Africa
Engelbrecht, S., Delaney, K. E., Kleinhans, B., Wilkinson, E., Tegally, H., Stander, T., van Zyl, G. U., Preiser, W., & de Oliveira, T. (2021) · Viruses · doi:10.3390/v13030526 · Cited by 24
Viral genome sequencing methods: benefits and pitfalls of current approaches
Jansz, N., & Faulkner, G. J. (2024) · Biochemical Society Transactions · doi:10.1042/bst20231322 · Cited by 27
Potdar, V. A., Vipat, V., Ramdasi, A. Y., Jadhav, S., Pawar-Patil, J., Walimbe, A. M., Patil, S., Choudhury, M. L., Shastri, J. S., Agrawal, S. R., et al. (2021) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_3418_20 · Cited by 24
Genotyping of the Major SARS-CoV-2 Clade by Short-Amplicon High-Resolution Melting (SA-HRM) Analysis
Díaz‐García, H., Guzmán-Ortiz, A. L., Ángeles-Floriano, T., Parra‐Ortega, I., López-Martı́nez, B., Martínez‐Saucedo, M., Aquino‐Jarquín, G., Sánchez‐Urbina, R., Quezada, H., & Granados-Riveron, J. T. (2021) · Genes · doi:10.3390/genes12040531 · Cited by 24
Fattahi, Z., Mohseni, M., Jalalvand, K., Moghaddam, F. A., Ghaziasadi, A., Keshavarzi, F., Yavarian, J., Jafarpour, A., Mortazavi, S. E., Ghodratpour, F., et al. (2021) · Transboundary and Emerging Diseases · doi:10.1111/tbed.14104 · Cited by 24
Gettings, J. R., Gold, J. A. W., Kimball, A. A., Forsberg, K., Scott, C., Uehara, A., Tong, S., Hast, M. A., Swanson, M. R., Morris, E., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab332 · Cited by 25
Recurrent Dissemination of SARS-CoV-2 Through the Uruguayan–Brazilian Border
Mir, D., Rego, N., Resende, P. C., Tort, F. L., Fernández-Calero, T., Noya, V., Brandes, M., Possi, T., Arleo, M., Reyes, N., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.653986 · Cited by 24
Genomic epidemiology of SARS-CoV-2 transmission lineages in Ecuador
Gutiérrez, B., Márquez, S., Prado-Vivar, B., Becerra-Wong, M., Guadalupe, J. J., Cândido, D. D. S., Fernández‐Cadena, J. C., Gabriel Morey-León, G., Armas-González, R., Andrade-Molina, D., et al. (2021) · Virus Evolution · doi:10.1093/ve/veab051 · Cited by 25
Self-citation
Metadata
- Authors
- Rambaut, A., Holmes, E. C., O’Toole, Á., Hill, V., McCrone, J. T., Ruis, C., du Plessis, L., & Pybus, O. G.
- Affiliations
- University of Edinburgh (GB)
- The University of Sydney (AU)
- University of Cambridge (GB)
- University of Oxford (GB)
- Corresponding author
- Rambaut, Andrew
- Holmes, Edward C.
- Pybus, Oliver G.
- ORCID
- Venue
- Nature Microbiology
- Published
- 2020-07-15
- Volume
- 5
- Issue
- 11
- Pages
- 1403-1407
- ISSN
- 2058-5276 (ISSN-L)
- PMC
- PMC7610519
- OpenAlex
- W3043124965
- Cited by
- 2,543
- References
- 18
- Citations by year
- 2026: 86 · 2025: 141 · 2024: 235 · 2023: 365 · 2022: 700 · 2021: 851 · 2020: 163
- FWCI
- 68.76
- Type
- journal article
- Language
- en
- Update notices
- addendum (2021-01-29)
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature Microbiology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- The Sydney eScholarship Repository (The University of Sydney) (submittedVersion)
- Funders
- Wellcome Trust (206298/Z/17/Z-ARTIC, FP7/2007–2013, Z/17/Z, 206298/Z/17/Z, 206298, 725422-ReservoirDOCS)
- European Commission (725422, 725422-RESERVOIRDOCS, 2007–2013, FP7 2007-2013, HORIZON2020, FP7/2007, COVID-19)
- Australian Research Council (FL170100022)
- FP7 Ideas: European Research Council (614725)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
- Keywords
- SARS-CoV-2, COVID-19 pandemic, virus nomenclature, phylogenetic lineages, genomic epidemiology
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Genotype, Humans, Phylogeny, Pneumonia, Viral, Genome, Viral, Molecular Epidemiology, Coronavirus Infections, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
